Capital Fund Management S.A. Takes Position in Cabot Co. (NYSE:CBT)

Capital Fund Management S.A. bought a new position in Cabot Co. (NYSE:CBT - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund bought 22,146 shares of the specialty chemicals company's stock, valued at approximately $2,022,000.

Several other hedge funds and other institutional investors have also bought and sold shares of the stock. R Squared Ltd purchased a new position in shares of Cabot during the fourth quarter valued at approximately $26,000. EverSource Wealth Advisors LLC raised its stake in Cabot by 37.2% during the 4th quarter. EverSource Wealth Advisors LLC now owns 808 shares of the specialty chemicals company's stock valued at $74,000 after buying an additional 219 shares during the last quarter. GAMMA Investing LLC grew its holdings in shares of Cabot by 10.7% in the fourth quarter. GAMMA Investing LLC now owns 1,348 shares of the specialty chemicals company's stock worth $123,000 after acquiring an additional 130 shares during the period. Manchester Capital Management LLC lifted its holdings in Cabot by 1,685.1% in the fourth quarter. Manchester Capital Management LLC now owns 1,678 shares of the specialty chemicals company's stock valued at $153,000 after acquiring an additional 1,584 shares during the period. Finally, KBC Group NV boosted its position in Cabot by 43.1% in the fourth quarter. KBC Group NV now owns 2,046 shares of the specialty chemicals company's stock worth $187,000 after purchasing an additional 616 shares during the last quarter. Institutional investors own 93.18% of the company's stock.

Cabot Price Performance

NYSE:CBT traded up $0.08 on Friday, reaching $78.40. 338,411 shares of the company's stock traded hands, compared to its average volume of 387,326. The stock has a 50-day simple moving average of $82.71 and a 200-day simple moving average of $94.90. The firm has a market cap of $4.25 billion, a PE ratio of 10.41, a P/E/G ratio of 0.74 and a beta of 1.04. Cabot Co. has a 12 month low of $73.63 and a 12 month high of $117.46. The company has a quick ratio of 1.29, a current ratio of 2.00 and a debt-to-equity ratio of 0.72.

Cabot (NYSE:CBT - Get Free Report) last announced its quarterly earnings data on Monday, February 3rd. The specialty chemicals company reported $1.76 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.74 by $0.02. Cabot had a net margin of 10.60% and a return on equity of 26.79%. Equities research analysts forecast that Cabot Co. will post 7.57 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on CBT shares. StockNews.com upgraded shares of Cabot from a "hold" rating to a "buy" rating in a research note on Thursday. UBS Group cut their price target on Cabot from $93.00 to $83.00 and set a "neutral" rating for the company in a report on Monday, April 7th. JPMorgan Chase & Co. lowered their price objective on Cabot from $105.00 to $85.00 and set an "underweight" rating on the stock in a research report on Friday, February 21st. Finally, Mizuho reduced their target price on shares of Cabot from $122.00 to $110.00 and set an "outperform" rating for the company in a report on Tuesday, January 7th.

Cabot Company Profile

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.